Donald Trump & Pfizer
6 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Donald Trump: Donald Trump initiated the United States — Medicaid pilot program and other initiatives aimed at reducing U.S. prescription drug prices.
Pfizer: Pfizer previously signed a deal with the administration regarding drug pricing and co-developed Xtandi with Astellas Pharma.
Apr 20, 2026 · 6 articles
Regulatory
Donald Trump: Donald Trump, US President, was a subject of discussion in the 'Washington Group' chat, which was reportedly set up to exchange messages when he did 'something wild and potentially damaging'.
Pfizer: Pfizer was mentioned in the context of a previous transparency dispute involving Ursula von der Leyen's text messages with its CEO, Albert Bourla, regarding COVID-19 vaccine contracts.
Jun 24, 2026 · 6 articles
Regulatory
Pfizer: Pfizer previously agreed to lower the cost of prescription drugs for United States — Medicaid following an executive order, setting a precedent for the current deal with Eli Lilly and Company and Novo Nordisk.
Nov 06, 2025 · 6 articles
Regulatory
Pfizer: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
NEWSDESK
Explore this relationship live
Track how Donald Trump and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard